The focus of research on yeast prions is now moving to exploit this established and highly tractable model system to elucidate the molecular basis of prion conver- 
The Role of the Yeast PrD in Prion Conversion
Mammalian PrP contains five complete copies of the octarepeat PHGGGWGQ at its N terminus, and expanOne of the most tantalizing sequence features of the Sup35p-PrD is the presence of five complete (and one sion in the number of octarepeats has been associated 
Conclusion
We have learned much about prion biology through the study of yeast prions and their associated PrDs, but caution must be exercised in extrapolating these findings directly to mammalian prion behavior. It must not be forgotten that mammalian PrP Sc is an infectious agent that can spread from cell to cell while there is no evidence of cell-to-cell transmission of yeast prions other than through cytoplasmic mixing. This apparent lack of infectivity of yeast prions may simply reflect their cytoplasmic location. Nevertheless, the recently published studies have added significantly to our understanding of the molecular basis of yeast prion conversion and maintenance. We now know the key sequence features of a yeast PrD that drive prion conversion, and the new data are consistent with a highly specific PrDPrD interaction mediating polymerization both in vivo and in vitro. For both Sup35p and Ure2p the in vitroformed polymers are clearly amyloid-like, but we must now determine whether Sup35p, Ure2p, and other yeast prions are present in cells in the same form. This, together with an understanding of the underlying protein structural framework, will allow us to build mechanistic models for prion conversion in yeast.
